Ameriprise Financial »

Contineum Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4M 210k 11.43

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
iShares S&P 500 Index (IVV)
Facebook Inc cl a (META)
Visa (V)
Lam Research (LRCX)
Alphabet Inc Class C cs (GOOG)
Bank of America Corporation (BAC)
Wal-Mart Stores (WMT)
Vanguard S&p 500 Etf idx (VOO)

View all positions for Ameriprise Financial

Top funds holding Contineum Therapeutics

Suvretta Capital Management
RA Capital Management
Johnson & Johnson
Franklin Resources
Vanguard Group
Balyasny Asset Management
Commodore Capital
FMR
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management

View all funds holding Contineum Therapeutics